-
News | 2018.03.12
The French Parliamentary Office of Science and Technology pays a visit to the Institut Pasteur
A delegation from the French Parliamentary Office of Science and Technology (OPECST), led by its first Vice-President Cédric Villani, visited the Institut Pasteur in Paris on March 8.This delegation, made up of French MPs Christophe Bouillon, Jean-Luc Fugit and Cédric Villani, and senators from the French upper house Roland Le Gleut, Pierre Médevielle and Angèle Préville, met with Stewart Cole,...
-
Document de presse | 2018.05.23
Dengue: investigating antibodies to identify at-risk individuals
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus of study for dengue specialists, and obtained new information that should help identify individuals at risk of infection. By modeling changes in antibody levels after...
-
News | 2018.11.08
Institut Pasteur scientists during the Great War
On August 3, 1914, war was declared between France and Germany. It was the most horrific and deadly war in history, during which alas, in Pasteur's own words, the law of blood and death prevailed. However, as Pasteur had foreseen, his work and that of other Institut Pasteur scientists saved the lives of thousands of soldiers. An excerpt from a talk at the Palais de la Découverte on Wednesday...
-
Document de presse | 2019.10.03
Dysentery: Shigella, bacteria with adaptation to respiration
Bacillary dysentery caused by the intestinal bacteria Shigella is a major health problem in tropical regions and developing countries. Complications from this infection lead to several hundred thousand deaths a year, primarily among infants. Researchers from Inserm and the Institut Pasteur have studied the mechanisms of Shigella virulence. They found that these bacteria are not only able to...
-
Document de presse | 2020.01.31
Institut Pasteur isolates strains of coronavirus 2019-nCoV detected in France
As well as sequencing the whole genome of coronavirus 2019-nCoV, the Institut Pasteur continued to work on the samples taken from the first confirmed cases. The quality of these initial samples enabled rapid cell-culture isolation of the new virus. The Institut Pasteur's scientists now have access to the virus responsible for the infection. The isolation of the virus paves the way for new...
-
News | 2020.02.27
Foreign travel – a tonic for the health?
All travelers can come into contact with health risks that are completely different from those they generally encounter on a daily basis. So it is vital to prepare thoroughly for any trip – and that involves consulting a specialist travel clinic such as the Institut Pasteur Medical Center (CMIP).Travel is a formative experience for young people – and young people often take a casual attitude to...
-
Article | 2020.07.27
The Institut Pasteur is a private, non-profit foundation
The Institut Pasteur is ideally placed to successfully pursue its primary missions of research, public health, education and the identification of research applications. Its many strengths include the outstanding quality of its staff, the excellence of its research and infrastructures, and the critical mass of the Institut Pasteur International Network.The Technology Transfer and Industrial...
-
Article | 2020.08.20
R&D collaborations
The combination of our scientific expertise and industrial awareness will enable you to identify innovative solutions to meet your challenges.
-
News | 2020.10.05
New Free On-Line Course Created By Institut Pasteur: Clinical Trials In Infectious And TropicalL Diseases
While clinical research has developed for many years in high income countries, it is becoming increasingly important in countries with limited resources. Indeed, beyond common pathologies, specific pathologies such as infectious and tropical diseases make it necessary to conduct trials adapted to the context of countries with limited resources. In addition, re-evaluations of therapeutic or...
-
News | 2020.10.05
New Edition Of The Free On-Line Mooc Malaria
Malaria remains a major public health problem in many low and middle-income countries in the tropics. In 2018, WHO estimates that there were around 228 million cases of malaria that caused 405,000 deaths, primarily in sub-Saharan Africa. While the intensive application of currently available malaria control tools has greatly reduced malaria transmission in many parts of the world where malaria is...